New diabetes drug enters final testing phase
NCT ID NCT07394114
Summary
This study is testing whether a new injectable medication called HDM1005 can help control blood sugar in people with type 2 diabetes who haven't yet started other diabetes drugs. About 240 participants will receive either the real medication or a placebo injection for 36 weeks, with everyone eventually getting the chance to try HDM1005. Researchers will measure changes in long-term blood sugar levels (HbA1c), body weight, and safety over 60 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chinese PLA General Hospital
RECRUITINGBeijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.